Alnylam Pharmaceuticals | ALNY - 이자 수익

주가
314.80
매일 변경
-5.62 -1.75%
매월
-7.24%
매년
24.21%
Q1 예상
303.95




이자 수익 변화 날짜
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 73M 8M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Takeda JPY 87.87B 43.48B 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09
Xencor USD 6.54M 710K 2025-09